Throughout the COVID-19 pandemic and into post-pandemic operation, medical device contract manufacturing organiza-tions (CMOs) have had to refine their operations with greater agility and flexibility. Not only have customer needs evolved in terms of both volume and customization, but traditional industry challenges (e.g., demanding development timelines) have compounded with emerging or worsening difficulties (e.g., supply chain complications).